PMID- 18705262
OWN - NLM
STAT- MEDLINE
DCOM- 20080902
LR  - 20101118
IS  - 0019-5847 (Print)
IS  - 0019-5847 (Linking)
VI  - 106
IP  - 1
DP  - 2008 Jan
TI  - Enoxaparin experience in percutaneous coronary intervention.
PG  - 12-5
AB  - To investigate the efficacy and safety of enoxaparin in 135 consecutive patients 
      who were undergoing emergency/non-emergency percutaneous coronary intervention 
      (PCI), a prospective, observational study of procedural anticoagulation was 
      carried out with enoxaparin in elective, primary PCI. Documentation of the 
      in-hospital clinical and angiographic outcomes was performed in eligible patients 
      undergoing elective or primary PCI. This data helped to capture how patients 
      while on anticoagulation with enoxaparin were being managed. As this was a 
      prospective observational registry and not a randomised controlled trial, there 
      was no single hypothesis from which to calculate the minimum sample size 
      required. We recorded outcomes with 135 consecutive patients undergoing PCI who 
      were enrolled in the study. While analysing the results the points taken into 
      consideration were: Patient demography, PCI, methods of haemostasis and timing of 
      sheath removal, dose and timing of enoxaparin and clinical and angiographic 
      outcome. Statistical analysis was performed using statistical analysis system 
      (SAS) software. Enoxaparin when used in PCI, can be a safe alternative to 
      unfractionated heparin (UFH).
FAU - Somani, V
AU  - Somani V
AD  - CHL-Apollo Hospital, Indore.
FAU - Trivedi, S
AU  - Trivedi S
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PL  - India
TA  - J Indian Med Assoc
JT  - Journal of the Indian Medical Association
JID - 7505608
RN  - 0 (Enoxaparin)
RN  - 0 (Fibrinolytic Agents)
SB  - IM
MH  - Angioplasty, Balloon, Coronary/*methods
MH  - Enoxaparin/*therapeutic use
MH  - Female
MH  - Fibrinolytic Agents/*therapeutic use
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Myocardial Ischemia/*therapy
MH  - Prospective Studies
MH  - Time Factors
MH  - Treatment Outcome
EDAT- 2008/08/19 09:00
MHDA- 2008/09/03 09:00
CRDT- 2008/08/19 09:00
PHST- 2008/08/19 09:00 [pubmed]
PHST- 2008/09/03 09:00 [medline]
PHST- 2008/08/19 09:00 [entrez]
PST - ppublish
SO  - J Indian Med Assoc. 2008 Jan;106(1):12-5.